SUSAN MARCHAND: Open Payments
NPI 1932110285 · GAINESVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,784 in 37 payments from 16 companies in 2025. Trend: 2023 $1,474 · 2024 $722 · 2025 $1,784
Food & beverage: $1,784
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $551 |
| Regeneron Healthcare Solutions, Inc. | 3 | $360 |
| Galderma Laboratories, L.P. | 4 | $160 |
| ABBVIE INC. | 7 | $149 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $146 |
| Lilly USA, LLC | 1 | $113 |
| Novartis Pharmaceuticals Corporation | 4 | $75 |
| UCB, Inc. | 2 | $41 |
| Kerecis Limited | 2 | $36 |
| GENZYME CORPORATION | 1 | $31 |
Products named: TREMFYA, DUPIXENT, ILUMYA, LIBTAYO, NEMLUVIO, SKYRIZI, COSENTYX, AKLIEF.
Industry payments across FL — which companies pay providers there.
